These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16800092)

  • 1. [Cervix cancer prevention--achieved success must be surpassed].
    Bengt A; Strander B
    Lakartidningen; 2006 May 17-30; 103(20):1630; author reply 1630. PubMed ID: 16800092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervix cancer can be prevented. Efficient HPV tests and highly-protective vaccine soon available for clinical use].
    Bistoletti P
    Lakartidningen; 2006 May 3-9; 103(18):1402. PubMed ID: 16729451
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
    Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HPV vaccination and testing can improve cervix cancer screening].
    Bistoletti P; Andersson S; Johansson BC
    Lakartidningen; 2008 Jan 9-15; 105(1-2):56-7. PubMed ID: 18293750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 8. The changing landscape for cervical screening.
    Farnsworth A
    Med J Aust; 2008 Jul; 189(1):6-7. PubMed ID: 18601631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
    Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
    BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human papillomavirus infection. Screening, treatment and vaccination].
    Aubin F
    Rev Prat; 2006 Nov; 56(17):1875-6. PubMed ID: 17243383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 13. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M
    Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer prevention.
    Franco EL; Drummond MF
    Vaccine; 2008 Sep; 26 Suppl 5():F1-2. PubMed ID: 18992378
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 16. Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?
    Covell JL; Stoler MH
    Am J Clin Pathol; 2007 Nov; 128(5):726-8. PubMed ID: 17951192
    [No Abstract]   [Full Text] [Related]  

  • 17. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
    Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
    Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ
    Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of cervical cancer prevention in Europe.
    Davies P; Bogdanovic-Guillion A; Grce M; Sancho-Garnier H
    Coll Antropol; 2007 Apr; 31 Suppl 2():11-6. PubMed ID: 17598500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.